StockData
Shoulder Innovations, Inc. logo

Shoulder Innovations, Inc. (SI) stock

SINYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 8/3062% above fair value
$21.92−0.01 (-0.05%)

Close on Nov 11, 2026Market cap $456.35MP/E –Yield –

Shoulder Innovations, Inc. grew revenue 54.9% to $64.49M over the twelve months to Sep 30, 2026. Free cash flow was -$42.69M. At the latest close the market valued the company at $456.35M.

Revenue
$64.49M
+54.9% vs. a year earlier
Operating income
-$35.11M
TTM Q3 2026
Free cash flow
-$42.69M
TTM Q3 2026
EPS, diluted
-$4.65
FY2025

Key statistics

Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2026

Valuation

Market cap
$456.35M
P/E ratio
–
Price to sales
7.08
Price to book
3.85
Dividend yield
–
Free cash flow yield
-9.35%

Fundamentals

Revenue
$64.49M
Net income
-$33.35M
EPS, diluted
-$4.65
Free cash flow
-$42.69M
Book value per share
$5.68
Diluted shares
21M

Trading

Next earnings
Mar 9, 2027 (estimated, after the close)
Previous close
$21.93
Open
$21.92
Day's range
$21.29 – $21.95
Volume
191,037
Average volume (20 days)
117,297
Index membership
Russell 2000 (since Sep 2025)
52-week range
$10.92 – $24.59
RSI (14 days)
66.9
Volatility (1 year)
68.5%
Relative volume
1.67×

On 1 of our idea list: Institutions accumulating

Index membership is inferred from the holdings of funds that track each index (IWM), as reported to the SEC for Jun 30, 2026. Join dates come from quarterly fund reports since 2019, so they are accurate to the quarter.

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 11, 2026. The S&P 500 is measured by the SPY fund.

PeriodSIS&P 500DifferenceSI per yearS&P 500 per year
1 month+20.9%-2.4%+23.3 pts
3 months+11.7%-1.2%+12.8 pts
Year to date+53.3%+12.3%+41.0 pts
1 year+93.0%+12.4%+80.5 pts
3 years+1653.6%+78.8%+1574.8 pts+159.8%+21.4%

Three years at a glance

Fiscal years 2023 to 2025 and trailing twelve months, USD

Revenue

$64.49M+54.9% YoY

Gross profit

$50.19M+57.3% YoY

Operating income

-$35.11M

Net income

-$33.35M

EPS, diluted

–

Free cash flow

-$42.69M
Reported periodTrailing twelve months

Press releases

Releases Shoulder Innovations filed with the SEC as exhibits to Form 8-K or 6-K

All press releases and earnings

About Shoulder Innovations

Surgical & Medical Instruments & Apparatus

The company develops and commercializes medical technology solutions focused on shoulder surgical care. Its offerings center on advanced implant systems for anatomic and reverse total shoulder arthroplasty, featuring proprietary glenoid and humeral stem technologies designed to improve stability and joint biomechanics. Complementing its implants, the company provides AI- and machine-learning-driven preoperative planning software that converts medical scans into 3D patient models, alongside a streamlined two-tray surgical instrumentation system. It serves orthopedic surgeons, hospitals, and outpatient surgery centers, supported by specialized clinical personnel and independent distributors.

Company profile, executives and history

Shoulder Innovations stock: common questions

What is Shoulder Innovations's stock price?

SI closed at $21.92 on Nov 11, 2026, down 0.05% on the day. Over the past 52 weeks it traded between $10.92 and $24.59.

What is Shoulder Innovations's market cap?

Shoulder Innovations was worth $456.35M at the close on Nov 11, 2026: the share price times the diluted shares outstanding.

What is SI's P/E ratio?

Shoulder Innovations lost money over fiscal 2025 (diluted EPS -$4.65), so it has no meaningful P/E ratio.

How much revenue does Shoulder Innovations make?

Shoulder Innovations reported revenue of $64.49M for the twelve months to Sep 30, 2026, up 54.9% from a year earlier.

Does Shoulder Innovations pay a dividend?

No. Shoulder Innovations has not paid a cash dividend over the last twelve months.

When does Shoulder Innovations report earnings next?

Shoulder Innovations is expected to report Q4 FY2026 results on Mar 9, 2027, after the close. The date is estimated from its past reporting pattern until the company confirms it.

How has SI stock performed over the past year?

Including dividends, SI returned +93.0% over the past year, against +12.4% for the S&P 500.

How many SI shares are sold short?

1M shares were sold short at the latest FINRA report, 5.65% of the float, or 7.7 days of average trading volume.

Who are Shoulder Innovations's competitors?

Companies most similar to Shoulder Innovations by business, industry and size include CARL, TELA, SSII, XTNT, SIBN.

See a number that looks wrong?